TAMPA GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website: https://www.tgh.org/

Clinical Trials

Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation

Phase 4

Completed

Conditions: End Stage Renal Disease

Interventions: Drug: CMVIG

First Posted Date: 2008-11-05

Last Posted Date: 2015-06-29

Lead Sponsor: Tampa General Hospital

Target Recruit Count: 26

Registration Number: NCT00784979

Locations: 🇺🇸
LifeLink HealthCare Institute, Tampa, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy